Managers / Q3 2021 · view latest →
Sivik Global Healthcare LLC
CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600
Reported Value
$419M
Q3 2021
Positions
43
Filings on Record
30
2019–present window
Filed
Nov 12, 2021
original filing
Summary
Sivik Global Healthcare LLC reported $419M in U.S.-listed holdings across 43 positions for Q3 2021.
Its largest position, HCA, represents 3.2% of the portfolio.
Compared with Q2 2021, the fund opened 12 new positions and exited 18.
Portfolio Metrics
Turnover
+45.5%
vs prior filed quarter
Top-10 Concentration
+25.7%
share of reported value
Largest Position
+3.2%
Hca Healthcare
New / Exited
12 / 18
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 95.6% · $400M
- ADR · 2.7% · $11M
- Other · 1.7% · $7M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SNNThermo Fisher Scientific Inc | NEW | +15.0K | 15.0K | +$9M | $9M |
| BDXBecton Dickinson and Co | NEW | +25.0K | 25.0K | +$6M | $6M |
| REGNSelect Medical Holdings Corp | NEW | +160.0K | 160.0K | +$6M | $6M |
| TMOWaters Corp | NEW | +15.0K | 15.0K | +$5M | $5M |
| OPCHOption Care Health Inc | NEW | +155.0K | 155.0K | +$4M | $4M |
| CYHCommunity Health Systems Inc | NEW | +315.0K | 315.0K | +$4M | $4M |
| MRVIMaravai LifeSciences Holdings | NEW | +75.0K | 75.0K | +$4M | $4M |
| TECHBio-Techne Corp | NEW | +7.5K | 7.5K | +$4M | $4M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2021
41 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | HCAHCA Healthcare Inchistory → | Cash Securities | 3.19% | $13M | 55.0K |
| 2 | S24Tenet Healthcare Corphistory → | Cash Securities | 3.17% | $13M | 200.0K |
| 3 | JNJJohnson & Johnsonhistory → | Cash Securities | 2.70% | $11M | 70.0K |
| 4 | THCUniversal Health Services Inchistory → | Cash Securities | 2.64% | $11M | 80.0K |
| 5 | Stryker Corp | Cash Securities | 2.46% | $10M | 39.0K |
| 6 | UNHZimmer Biomet Holdings Inchistory → | Cash Securities | 2.45% | $10M | 70.0K |
| 7 | MDTMedtronic PLChistory → | Cash Securities | 2.40% | $10M | 80.0K |
| 8 | BSXBoston Scientific Corphistory → | Cash Securities | 2.28% | $10M | 220.0K |
| 9 | BAXBaxter International Inchistory → | Cash Securities | 2.21% | $9M | 115.0K |
| 10 | DHRDanaher Corphistory → | Cash Securities | 2.18% | $9M | 30.0K |
| 11 | MCKMcKesson Corphistory → | Cash Securities | 2.14% | $9M | 45.0K |
| 12 | AVTRAvantor Inchistory → | Cash Securities | 2.05% | $9M | 210.0K |
| 13 | SNNThermo Fisher Scientific Inchistory → | Cash Securities | 2.05% | $9M | 15.0K |
| 14 | IQVIQVIA Holdings Inchistory → | Cash Securities | 2.00% | $8M | 35.0K |
| 15 | ABTAbbott Laboratorieshistory → | Cash Securities | 1.98% | $8M | 70.0K |
| 16 | Charles River Laboratories In | Cash Securities | 1.97% | $8M | 20.0K |
| 17 | Catalent Inc | Cash Securities | 1.94% | $8M | 60.9K |
| 18 | LLYEli Lilly & Cohistory → | Cash Securities | 1.93% | $8M | 35.0K |
| 19 | MRKMerck & Co Inchistory → | Cash Securities | 1.79% | $8M | 100.0K |
| 20 | EHCEncompass Health Corphistory → | Cash Securities | 1.79% | $8M | 100.0K |
| 21 | GMEDGlobus Medical Inchistory → | Cash Securities | 1.74% | $7M | 95.0K |
| 22 | Laboratory Corp of America Ho | Cash Securities | 1.68% | $7M | 25.0K |
| 23 | CORAmerisourceBergen Corphistory → | Cash Securities | 1.64% | $7M | 57.5K |
| 24 | CNCCentene Corphistory → | Cash Securities | 1.49% | $6M | 100.0K |
| 25 | BDXBecton Dickinson and Cohistory → | Cash Securities | 1.47% | $6M | 25.0K |
| 26 | BRKRBruker Corphistory → | Cash Securities | 1.40% | $6M | 75.0K |
| 27 | REGNSelect Medical Holdings Corphistory → | Cash Securities | 1.38% | $6M | 160.0K |
| 28 | MOHMolina Healthcare Inchistory → | Cash Securities | 1.30% | $5M | 20.0K |
| 29 | TMOWaters Corphistory → | Cash Securities | 1.28% | $5M | 15.0K |
| 30 | BMRNBioMarin Pharmaceutical Inchistory → | Cash Securities | 1.20% | $5M | 65.0K |
| 31 | SYKUnitedHealth Group Inchistory → | Cash Securities | 1.17% | $5M | 12.5K |
| 32 | HUMHumana Inchistory → | Cash Securities | 1.16% | $5M | 12.5K |
| 33 | Hologic Inc | Cash Securities | 1.06% | $4M | 60.0K |
| 34 | OPCHOption Care Health Inc | Cash Securities | 0.90% | $4M | 155.0K |
| 35 | CYHCommunity Health Systems Inc | Cash Securities | 0.88% | $4M | 315.0K |
| 36 | MRVIMaravai LifeSciences Holdings | Cash Securities | 0.88% | $4M | 75.0K |
| 37 | TECHBio-Techne Corp | Cash Securities | 0.87% | $4M | 7.5K |
| 38 | DGXRegeneron Pharmaceuticals Inc | Cash Securities | 0.87% | $4M | 6.0K |
| 39 | GRFSGrifols SA | Cash Securities | 0.70% | $3M | 200.0K |
| 40 | LHC Group Inc | Cash Securities | 0.56% | $2M | 15.0K |
| 41 | ACHCAcadia Healthcare Co Inc | Cash Securities | 0.29% | $1M | 18.9K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $132M | 34 | Apr 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $345M | 49 | Jan 21, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $344M | 44 | Oct 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $368M | 46 | Jul 25, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $185M | 31 | Apr 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $190M | 38 | Jan 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $236M | 35 | Nov 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $278M | 38 | Jul 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $427M | 47 | May 1, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $239M | 39 | Feb 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $198M | 33 | Nov 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $428M | 43 | Aug 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $233M | 40 | May 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $213M | 39 | Feb 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $180M | 41 | Nov 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $176M | 38 | Aug 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $242M | 49 | May 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $233M | 45 | Feb 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $419M | 43 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $512M | 49 | Aug 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $274M | 47 | May 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $245M | 38 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $232M | 38 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $302M | 52 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $253M | 40 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $269M | 50 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $198M | 45 | Nov 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $414M | 62 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $271M | 61 | May 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $186M | 48 | Feb 12, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.